What is Vito Larocca's specialty?

Vito Larocca (NPI 1376637991) is a Medicare-billing provider whose primary specialty is Ophthalmology in Staten Island, NY.

Where does Vito Larocca practice?

Vito Larocca practices in Staten Island, NY, based on the location reported in the CMS Medicare provider datasets for NPI 1376637991.

How much does Medicare pay Vito Larocca?

Medicare Part B utilization, prescribing (Part D), MIPS quality scores, and industry payments for Vito Larocca (NPI 1376637991) are detailed on this CareTrace profile.

PROVIDER PROFILE · NPI 1376637991

Vito Larocca

OphthalmologyStaten Island, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$2K

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Timolol Maleate17 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Vito Larocca's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
STATEN ISLAND UNIVERSITY HOSPITAL	41	94

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ	71	138
STATEN ISLAND UNIVERSITY HOSPITAL	45	108
RICHMOND MEDICAL CENTER	30	73
Daniel Rosberger Ophthalmology · New York, NY	27	48

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history